United States · FDA National Drug Code directory
nicotine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0363-1825_ee4e4e2b-9f71-4e03-a214-ffcaa9e0e78e
- Product NDC
- 0363-1825
- Form
- LOZENGE
- Composition / generic term
- nicotine polacrilex
- Labeler
- Walgreen Company
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20181108
- Source listing expiry
- 20261231
Source-listed ingredients
- NICOTINE — 2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 CONTAINER in 1 CARTON (0363-1825-07) / 27 LOZENGE in 1 CONTAINER · 0363-1825-07
- 27 LOZENGE in 1 CONTAINER (0363-1825-09) · 0363-1825-09
- 1 CONTAINER in 1 CARTON (0363-1825-60) / 20 LOZENGE in 1 CONTAINER · 0363-1825-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →